37 filings
8-K
ALXO
Alx Oncology Holdings Inc
9 May 24
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
8-K
ALXO
Alx Oncology Holdings Inc
2 May 24
Departure of Directors or Certain Officers
4:07pm
8-K
ALXO
Alx Oncology Holdings Inc
7 Mar 24
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
ALXO
Alx Oncology Holdings Inc
26 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
ALXO
Alx Oncology Holdings Inc
13 Nov 23
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
8-K
802uc6 65l0n7u7j5fpy
6 Oct 23
ALX Oncology Announces Pricing of Public Offering
6:06am
8-K
hv8sxtcur 9xga
4 Oct 23
Results of Operations and Financial Condition
5:21pm
8-K
rj38am7 wgyv5esofpj
4 Oct 23
Other Events
8:00am
8-K
3ol0j725bypkeg9b 68
6 Sep 23
Departure of Directors or Certain Officers
4:05pm
8-K
ejy6d6p6s18i
10 Aug 23
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
4:05pm
8-K
ytnl8rxw7zlmdpemmrn7
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
8:45am
8-K
4iy joi7ibtlygksq
11 May 23
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
4:03pm
8-K
4zmqipd
13 Mar 23
Regulation FD Disclosure
8:01am
8-K
pqon wblx
9 Mar 23
Results of Operations and Financial Condition
4:02pm
8-K
t80bhu1md5ruzvw4f54r
29 Nov 22
ALX Oncology Appoints Scott Garland to its Board of Directors
9:11am
8-K
wege1p qo3ghbs5goi
8 Nov 22
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm
8-K
hy3ddumudqv
31 Oct 22
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
7:30am
8-K
961667cx
8 Aug 22
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:03pm
8-K
odq jpnawzlbedkwbm7
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
705rlo90h6s
9 May 22
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm